Mycobacterium research and diagnosis
Mycobacterium research and diagnosis is a research topic within Epidemiology. Science Explorer counts 50k research works in it since 1950. 13.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and epidemiology of nontuberculous mycobacterial diseases, with a particular emphasis on Mycobacterium avium and Mycobacterium abscessus. It covers topics such as the impact of genotypic studies, antibiotic resistance, prevalence in specific patient populations (e.g., Crohn's disease, cystic fibrosis), and environmental sources. The cluster also delves into genomic and comparative genomic studies supporting the division of the genus Mycobacterium.
- Nontuberculous Mycobacteria
- Mycobacterium avium
- Mycobacterium abscessus
- Epidemiology
- Diagnosis
- Treatment
- Genomic Studies
- Crohn's Disease
- Cystic Fibrosis
- Antibiotic Resistance
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 6.9k per year above
- Top-10% rate
- 13.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +10% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Mycobacterium research and diagnosis research?
By volume, the United States and China publish the most (1.4k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 1.1k works
- 3 India 644 works
- 4 Japan 357 works
- 5 United Kingdom 263 works
- 6 Brazil 251 works
- 7 South Korea 200 works
- 8 France 199 works
- 9 Spain 170 works
- 10 Germany 168 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Mycobacterium research and diagnosis research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Mycobacterium research and diagnosis research, followed by Capital Medical University and Post Graduate Institute of Medical Education and Research.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 23 works
- 2 Capital Medical UniversityChina 21 works
- 3 Post Graduate Institute of Medical Education and ResearchIndia 19 works
- 4 Beijing Chest HospitalChina 19 works
- 5 All India Institute of Medical SciencesIndia 19 works
- 6 University of North Carolina at Chapel HillUnited States 19 works
- 7 University of Colorado DenverUnited States 17 works
- 8 Harvard UniversityUnited States 16 works
- 9 Sichuan UniversityChina 16 works
- 10 University of PittsburghUnited States 15 works
Who are the leading researchers in Mycobacterium research and diagnosis?
The most-cited researchers publishing on Mycobacterium research and diagnosis include J. Ernst and Roderick J. Hay.
- 1 J. Ernst United States 4.4k citations
- 2 Roderick J. Hay United Kingdom 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Mycobacterium research and diagnosis research done?
The largest centres of Mycobacterium research and diagnosis research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Denver and Cape Town.
Largest cities, 2022–2025
Where it is the local speciality
- DenverUS · 34.4 works7.8×
- Cape TownZA · 21.1 works7.5×
Location quotient: how much more of its research is in Mycobacterium research and diagnosis than the world average.
Where is the best place to study Mycobacterium research and diagnosis?
Among universities, judged by research, London School of Hygiene & Tropical Medicine, University of Colorado Denver and Capital Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | London School of Hygiene & Tropical MedicineUnited Kingdom | 64.5 | 33.5% | 8.1× | 8 | +57.7% |
| 2 | University of Colorado DenverUnited States | 49.6 | 12.3% | 8.0× | 17 | +40.9% |
| 3 | Capital Medical UniversityChina | 47.3 | 17.8% | 5.3× | 20 | +4.7% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 44.8 | 16.8% | 3.5× | 23 | +14.2% |
| 5 | Harvard UniversityUnited States | 44.2 | 24.1% | 1.9× | 16 | +22.6% |
| 6 | Washington University in St. LouisUnited States | 42.0 | 31.7% | 2.1× | 10 | +63.5% |
| 7 | University of PittsburghUnited States | 41.6 | 25.4% | 2.9× | 15 | -4.0% |
| 8 | Post Graduate Institute of Medical Education and ResearchIndia | 41.3 | 2.2% | 8.5× | 19 | +30.0% |
| 9 | Zhejiang UniversityChina | 40.9 | 35.3% | 0.9× | 12 | -23.7% |
| 10 | Colorado State UniversityUnited States | 39.6 | 27.9% | 4.2× | 10 | -16.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Mycobacterium research and diagnosis research growing?
Output in 2018–2022 was 10% higher than in 2013–2017, peaking in 2019. The fastest-growing topics are Mycobacterium research and diagnosis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.